PharmAccess is a group of non-profit organizations dedicated to improving access to quality healthcare in Africa. PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
This integrated approach is made possible by the following organizations:
Through a collaboration of researchers from the Amsterdam Institute of Global Health and Development (AIGHD), PharmAccess Foundation and Getrude’s Children’s Hospital, a study was conducted to evaluate the antibiotic prescriptions in primary care in Nairobi. This work was done using data from the M-TIBA platform.
The two main aims of this study were to quantify antibiotic prescriptions for the treatment of ARIs and explore the factors that underlie antibiotic (overprescription in primary care. In two outreach and mobile primary clinics in Nairobi, a mixed-method study was conducted, and data collected on M-TIBA was analyzed. By using the mobile platform as a data source, it became possible to link the diagnoses patients received at clinics to the medications prescribed at pharmacies. In addition, interviews were performed with clinicians and patients to explain the findings.
The data showed that the most frequent patient diagnoses were ARIs (38.8%). Of all prescribed medications, 25.6 percent were antibiotics. Furthermore, almost 80 percent of ARIs were treated with antibiotics; this exceeds levels recommended by national and international treatment guidelines.
The interviews resulted in insights from both clinicians and patients. Clinicians cited high patient load as the main reason for overprescriptions. Some patients stated they would visit another health facility if not provided with antibiotic medicines. Mothers of sick children also insisted on antibiotics because they perceived the disease as more severe than it was.
Overall, the findings demonstrated the clear potential of mobile health platforms to successfully quantify antibiotic prescriptions in a real-world setting.
